These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32410792)

  • 1. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC): A report of 2,781 cases in a Chinese population.
    Zhu Y; Song Y; Xu G; Fan Z; Ren W
    Chin J Cancer Res; 2020 Apr; 32(2):140-148. PubMed ID: 32410792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLINICAL IMPACT OF NON-INVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES ON THE RISK OF MALIGNANCY IN THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A META-ANALYSIS OF 14,153 RESECTED THYROID NODULES.
    Vuong HG; Tran TTK; Bychkov A; Jung CK; Nakazawa T; Kakudo K; Katoh R; Kondo T
    Endocr Pract; 2019 May; 25(5):491-502. PubMed ID: 30657357
    [No Abstract]   [Full Text] [Related]  

  • 3. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
    Zhou H; Baloch ZW; Nayar R; Bizzarro T; Fadda G; Adhikari-Guragain D; Hatem J; Larocca LM; Samolczyk J; Slade J; Rossi ED
    Cancer Cytopathol; 2018 Jan; 126(1):20-26. PubMed ID: 28941185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the reclassification of NIFTP as an uncertain tumour on risk of malignancy for the diagnostic categories according to the Bethesda system for reporting thyroid cytopathology.
    Kopczyński J; Suligowska A; Niemyska K; Palyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
    Endokrynol Pol; 2019; 70(3):232-236. PubMed ID: 30845342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features and the risk of malignancy in The Bethesda System for the Reporting of Thyroid Cytopathology.
    Elliott Range D; Jiang XS
    Diagn Cytopathol; 2020 Jun; 48(6):531-537. PubMed ID: 32167682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology?
    Kopczyński J; Suligowska A; Niemyska K; Pałyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
    Endocr Pathol; 2020 Jun; 31(2):143-149. PubMed ID: 32236858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience.
    Kim M; Kim JE; Kim HJ; Chung YR; Kwak Y; Park SY
    J Pathol Transl Med; 2018 May; 52(3):171-178. PubMed ID: 29614546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Is Not a Cytological Diagnosis, but It Influences Cytological Diagnosis Outcomes: A Systematic Review and Meta-Analysis.
    Haaga E; Kalfert D; Ludvíková M; Kholová I
    Acta Cytol; 2022; 66(2):85-105. PubMed ID: 34781293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing noninvasive follicular thyroid neoplasm with papillary-like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS/FLUS and FN/SFN.
    Li W; Sciallis A; Lew M; Pang J; Jing X
    Diagn Cytopathol; 2018 Feb; 46(2):148-153. PubMed ID: 29193839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) - An 8-year tertiary center experience in Thailand.
    Thewjitcharoen Y; Butadej S; Nakasatien S; Chotwanvirat P; Porramatikul S; Krittiyawong S; Lekpittaya N; Himathongkam T
    J Clin Transl Endocrinol; 2019 Jun; 16():100175. PubMed ID: 30815363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.
    Bongiovanni M; Giovanella L; Romanelli F; Trimboli P
    Thyroid; 2019 Feb; 29(2):222-228. PubMed ID: 30426887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of The Bethesda System for Reporting Thyroid Cytopathology.
    Sauter JL; Lehrke H; Zhang X; Al Badri OT; Rodriguez-Gutierrez R; Delivanis DA; Singh Ospina N; Donegan D; Hamidi O; Iñiguez-Ariza N; Sharma A; Kittah NEN; Tamhane SU; Hurtado Andrade MD; Kotwal A; Jenkins SM; Spears G; Rivera M; Dean DS; Henry MR
    Am J Clin Pathol; 2019 Sep; 152(4):502-511. PubMed ID: 31305880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RISK OF MALIGNANCY IN THYROID CYTOLOGY: THE IMPACT OF THE RECLASSIFICATION OF NONINVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP).
    Ventura M; Melo M; Fernandes G; Carrilho F
    Endocr Pract; 2019 Jul; 25(7):642-647. PubMed ID: 30865528
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of noninvasive follicular thyroid neoplasm with papillary-like nuclear features and change in risk of malignancy for "The Bethesda System for Reporting Thyroid Cytology".
    Sung S; Margolskee E; Chen D; Tiscornia-Wasserman P
    J Am Soc Cytopathol; 2019; 8(3):133-140. PubMed ID: 31097289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of The Bethesda System for Reporting Thyroid Cytopathology in a Chinese population: An analysis of 13 351 specimens.
    Ke J; Jianyong L; Ying L; Genpeng L; Linlin S; Zhihui L; Jinnan L; Xueying S; Yong J; Jingqiang Z
    Diagn Cytopathol; 2019 Sep; 47(9):876-880. PubMed ID: 31074206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indeterminate nodules by the Bethesda system for reporting thyroid cytopathology in Israel: Frequency, and risk of malignancy after reclassification of follicular thyroid neoplasm with papillary-like features.
    Rosenblum RC; Shtabsky A; Marmor S; Trejo L; Yaish I; Barnes S; Yehuda M; Stern N; Silman Z; Tordjman KM
    Eur J Surg Oncol; 2019 Jul; 45(7):1182-1187. PubMed ID: 30928335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the Reclassification of "Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma" to "Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features" on the Bethesda System for Reporting Thyroid Cytopathology: A Large Academic Institution's Experience.
    Lau RP; Paulsen JD; Brandler TC; Liu CZ; Simsir A; Zhou F
    Am J Clin Pathol; 2017 Dec; 149(1):50-54. PubMed ID: 29272354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
    Higuchi M; Hirokawa M; Kanematsu R; Tanaka A; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2018 Dec; 65(12):1193-1198. PubMed ID: 30282887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Review and Meta-analysis of the Impact of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Cytological Diagnosis and Thyroid Cancer Prevalence.
    Ruanpeng D; Cheungpasitporn W; Thongprayoon C; Hennessey JV; Shrestha RT
    Endocr Pathol; 2019 Sep; 30(3):189-200. PubMed ID: 31338752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified reporting approach for thyroid FNA in the NIFTP era: A 1-year institutional experience.
    Mito JK; Alexander EK; Angell TE; Barletta JA; Nehs MA; Cibas ES; Krane JF
    Cancer Cytopathol; 2017 Nov; 125(11):854-864. PubMed ID: 28902465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.